GlaxoSmithKline also registered Retrovir 300 mg x 60, Retrovir 250 mg x 40 and Trizivir 750 mg x 60 under the Regulation in 2004, but there were no sales under tiered prices of these products in the reporting period.
GlaxoSmithKline rreġistrat ukoll Retrovir 300 mg x 60, Retrovir 250 mg x 40, u Trizivir 750 mg x 60 skont ir-Regolament fl-2004, iżda ma kienx hemm bejgħ taħt il-prezzijiet f'saffi ta' dawn il-prodotti matul il-perjodu ta' rapportar.